{"id":3959,"date":"2022-11-02T09:17:11","date_gmt":"2022-11-02T01:17:11","guid":{"rendered":"https:\/\/regask.com\/?p=3959"},"modified":"2024-10-21T03:38:31","modified_gmt":"2024-10-20T19:38:31","slug":"neuer-dengue-impfstoff-zugelassen","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/new-dengue-vaccine-approved\/","title":{"rendered":"Neuer Impfstoff zum Schutz der Menschen in der EU und weltweit\u2026"},"content":{"rendered":"
Am 13. Oktober 2022 hat der Ausschuss f\u00fcr Humanarzneimittel (CHMP) des Europ\u00e4ische Arzneimittel-Agentur (EMA)<\/a> \u00e4u\u00dferte sich positiv zum Dengue-Vierfachimpfstoff (Lebendimpfstoff, abgeschw\u00e4cht). Dieser Impfstoff dient der Vorbeugung der Dengue-Erkrankung und senkt das Risiko eines Krankenhausaufenthalts bei Personen ab 4 Jahren.<\/div>\n
<\/div>\n
Inzwischen laufen auch in Lateinamerika und Asien beh\u00f6rdliche Pr\u00fcfungen zu diesem Dengue-Vierfachimpfstoff.<\/div>\n
<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Kontaktieren Sie RegASK, um mehr \u00fcber regulatorische \u00c4nderungen in der EU zu erfahren.\u00a0<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\t\tKontaktieren Sie RegASK f\u00fcr weitere Details<\/span>\n\t<\/a>\n\n\n\t\tMehr lesen<\/span>\n\t<\/a>\n\n

\n\n\t
\n\t\t\t\t
\n\t\t\t\n\t\t\t\n\n\t\tLesen Sie Fallstudien aus der Pharma- und Biotech-Industrie<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n
\n
\n
<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

On 13 October 2022, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) expressed a positive opinion for the Dengue Tetravalent Vaccine (Live, Attenuated). This vaccine is used for the prevention of dengue disease, including lowering the risk of hospitalisation, in individuals from 4 years of age. In the…<\/p>","protected":false},"author":39,"featured_media":3960,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[40],"class_list":["post-3959","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-latest-insights"],"acf":[],"yoast_head":"\nNew Dengue Vaccine Approved | RegASK<\/title>\n<meta name=\"description\" content=\"A new vaccine to protect against dengue has been approved. Get the details and regulatory updates from RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/neuer-dengue-impfstoff-zugelassen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Vaccine to Protect People in the EU and Worldwide against Dengue\" \/>\n<meta property=\"og:description\" content=\"A new vaccine to protect against dengue has been approved. Get the details and regulatory updates from RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/neuer-dengue-impfstoff-zugelassen\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-02T01:17:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-20T19:38:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"New Vaccine to Protect People in the EU and Worldwide a…\",\"datePublished\":\"2022-11-02T01:17:11+00:00\",\"dateModified\":\"2024-10-20T19:38:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/\"},\"wordCount\":160,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/\",\"name\":\"New Dengue Vaccine Approved | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"datePublished\":\"2022-11-02T01:17:11+00:00\",\"dateModified\":\"2024-10-20T19:38:31+00:00\",\"description\":\"A new vaccine to protect against dengue has been approved. Get the details and regulatory updates from RegASK.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/new-dengue-vaccine-approved\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png\",\"width\":1600,\"height\":1200,\"caption\":\"New Vaccine To Protect People In The Eu And Worldwide Against Dengue\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Neuer Dengue-Impfstoff zugelassen | RegASK","description":"Ein neuer Impfstoff gegen Dengue-Fieber wurde zugelassen. Details und regulatorische Updates finden Sie in RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/neuer-dengue-impfstoff-zugelassen\/","og_locale":"de_DE","og_type":"article","og_title":"New Vaccine to Protect People in the EU and Worldwide against Dengue","og_description":"A new vaccine to protect against dengue has been approved. Get the details and regulatory updates from RegASK.","og_url":"https:\/\/regask.com\/de\/neuer-dengue-impfstoff-zugelassen\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2022-11-02T01:17:11+00:00","article_modified_time":"2024-10-20T19:38:31+00:00","og_image":[{"width":870,"height":653,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya-870x653.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Benoit Trouwaert","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/#article","isPartOf":{"@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"New Vaccine to Protect People in the EU and Worldwide a…","datePublished":"2022-11-02T01:17:11+00:00","dateModified":"2024-10-20T19:38:31+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/"},"wordCount":160,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","keywords":["Latest Insights"],"articleSection":["Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/","url":"https:\/\/regask.com\/new-dengue-vaccine-approved\/","name":"Neuer Dengue-Impfstoff zugelassen | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","datePublished":"2022-11-02T01:17:11+00:00","dateModified":"2024-10-20T19:38:31+00:00","description":"Ein neuer Impfstoff gegen Dengue-Fieber wurde zugelassen. Details und regulatorische Updates finden Sie in RegASK.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/new-dengue-vaccine-approved\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/new-dengue-vaccine-approved\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/ema-recommends-approval-of-the-first-vaccine-to-protect-adults-against-chikungunya.png","width":1600,"height":1200,"caption":"New Vaccine To Protect People In The Eu And Worldwide Against Dengue"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"Benoit Trouwaert"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/3959","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=3959"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/3959\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/3960"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=3959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=3959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=3959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}